Metabolic Dysfunction-Associated Steatotic Liver Disease and PeripheralArterial Disease: Associations and Treatment Considerations
MASLD and PAD frequently coexist. Targeting both conditions is expected to reduce the elevated cardiovascular risk observed in patients affected by both MASLD and PAD.
Authors
- Antonis Goulas (ORCID: https://orcid.org/0000-0002-6189-594X)
- Myrsini Orfanidou
- Stergios A. Polyzos
- Jannis Kountouras
Institutions
- Aristotle University of Thessaloniki (GR)
Publication Details
- Journal
- Current Vascular Pharmacology
- Published
- 2026-01-15
- DOI
- https://doi.org/10.2174/0115701611414052251127074106
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00